Anthill Ventures Announces New Cohort of Lumos Health Programme for Startups

HYDERABAD: Venture capital firm Anthill Ventures announced a new cohort for its Lumos Health programme. The programme is designed for startups with disruptive solutions and health technologies. Its focus is on verticals such as oncology, fertility, maternal health, genomics, cutting edge diagnostic, digital health and longevity.

The programme will provide startups with access to Anthill's global network of investors, mentors, and industry experts, as well as resources designed to help startups grow their businesses.

It also provides startups with access to 51 hospitals across the country through partners. Startups will be provided with opportunities, access to wet lab facilities, clinical validation support, and evaluation of their market-ready solutions. The programme is also supported by cancer care provider partner HealthCare Global (HCG). It will also support startups on regulatory processes, funding advice and market access.

"We recognise the potential of startups to drive change and solve real-world problems. We are committed to providing startups with the resources and expertise they need to succeed,” said Prasad Vanga, founder and managing partner of Anthill Ventures.

Lumos Health has evaluated over 500 startups and 11 startups successfully qualified for their scaling programmes, a release said.